ENTITY
China Resources Pharmaceutical Group

China Resources Pharmaceutical Group (3320 HK)

104
Analysis
Health Care • Hong Kong
China Resources Pharmaceutical Group is an integrated pharmaceutical company engaged in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. Its offerings include chemical drugs, traditional Chinese medicine, biological drugs, and nutritional products, covering various therapeutic areas. The company also provides warehousing, logistics, and supply chain solutions. It was formally established in 2007 and is headquartered in Hong Kong.
more
•27 Feb 2018 11:34

China Drug Distribution: More "Two Invoice" Changes

The restructuring of China's drug distribution industry continues with Baiyunshan Phrmcl Hldgs Co Ltd (874 HK)'s pending buyout of Walgreens Boots...

Share
bullish•Sinopharm Group
•03 Dec 2017 02:23

Walgreens Invests in Sinopharm Retail Arm

Walgreens Boots Alliance Inc (WBA US) has agreed to buy a 40% stake in Sinopharm Group Co H (1099 HK) 's Guoda Drug Store chain (held by...

Share
•17 Nov 2017 02:46

Shanghai Pharma Gets Cardinal Health Deal

Shanghai Pharmaceuticals H (2607 HK) has agreed to acquire Cardinal Health Inc (CAH US) 's China distribution business for US$1.2 billion (subject...

Share
•02 Nov 2017 01:42

Deceleration Likely Driving Cardinal Valuation

One of the questions posed during the discussion of Cardinal Health Inc (CAH US) 's plan to sell its China drug distribution business was the...

Share
bullish•Sinopharm Group
•25 Jul 2017 23:21

Cardinal to Depart China: A Good Play for Distributors

Cardinal Health Inc (CAH US) has confirmed press reports that it is evaluating strategic options for its China distribution business. The rumored...

Share
x